The Ontario Clinical Oncology Group is a Canadian academic trials group based at the Juravinski Hospital in Hamilton that designs and runs investigator-led cancer trials; in OnCo it leads LUMINA, the radiotherapy-omission study in low-risk luminal A breast cancer.
The Ontario Clinical Oncology Group (OCOG) works with investigators to design and conduct clinical trials through collaboration and scientific and methodological rigour; its office is at the Juravinski Hospital, G (60) Wing, 711 Concession Street, Hamilton, Ontario, with a McMaster University contact address (ocog.ca). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class, with the British Columbia Cancer Agency and McMaster University as collaborators) of LUMINA (NCT01791829, phase 2, omission of radiotherapy after breast-conserving surgery in low-risk luminal A breast cancer), the trial recorded in OnCo. It has no products of its own.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Ontario Clinical Oncology Group, including child institutions. 8 works · 32 citations · 38% open access · 25% clinical trials · 0% reviews.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.
Shares HR-positive / HER2-negative breast cancer and the tag cooperative-group.